An OS to Evaluate the Safety & Efficacy of Fixed Dose Combination Therapy With Atorvastatin and Ezetimibe
Clinical trial NCT05559606 · COMPLETED
Trial details
- NCT number
- NCT05559606
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-09-07
- Primary completion
- 2025-07-30
- Enrollment
- 1839
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.